Figure 1.
Representation of CLDN18.2 in gastric cancer cells, and structure and interaction with anti-CLDN18.2 Zolbetuximab—designed in Biorender.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.